Vesalius Longevity Labs Inc. raised $30,112,500 (Vancouver, A1)

LIVE PUBLIC DATA Source: SEC EDGAR Form D filings (U.S. Securities and Exchange Commission) · Last refreshed: Wed, 04 Nov 2026 01:28:40 GMT

Vesalius Longevity Labs Inc. plus every comparable record, with all columns and source links, as one CSV.

Not investment advice and not an offer or solicitation to buy or sell any security.

83 / 100 vendor spend propensity

Estimated post-raise budget for CPA / Tax / Audit services: $602,250 (heuristic)

  • Operating company: new capital typically funds hiring, facilities and vendors.
  • Raised $30,112,500 so far: a large raise.
  • Healthcare & Life Sciences companies are a strong fit for CPA / Tax / Audit services.
  • New filing (not an amendment): the raise is fresh.
  • Filed 1 day ago.
FieldValue
IndustryPharmaceuticals (Healthcare & Life Sciences)
Operating companyYes
Exemption506(b)
Amount sold$30,112,500
Total offering$30,112,500
Investors so far62
First sale2026-10-28
Filed2026-11-03
EntityCorporation

Executives and related persons (from the filing)

  • PRADEEP ALBERT: Executive Officer
  • CHRISTOPHER R COOPER: Executive Officer
  • TIMMI STUMP: Executive Officer
  • JAMES MCROBERTS: Director
  • KEVIN SERRE: Director
  • ROBERT MCCUE: Director
  • JOEL LEONOFF: Director
  • KEVIN MAYER: Director
  • DAVID ADELMAN: Director
  • LEE APPLBAUM: Director

View the filing on SEC EDGAR

Markdown version

Vesalius Longevity Labs Inc. vs. top 3 peers

OrganizationLocationCapital raisedRecord date
Vesalius Longevity Labs Inc.Vancouver$30,112,5002026-11-03
XRHealth, Inc.Needham$16,253,0292026-10-23
Trellis Bioscience, Inc.Redwood City$9,093,0002026-10-29
28bio, Inc.Metairie$8,524,9452026-10-29

Related records

Newly funded Healthcare & Life Sciences companies (SEC Form D)

Get new raises like this every morning

FormDPulse emails you newly funded companies that match your ideal customer profile.

See plans

Often used together

Or get the Advisor Prospecting Bundle for $14.99 one-time: Full CSV unlock of newly funded companies plus a grant readiness pack.